Global initiative addressing personalised and preventative health to be launched during the event ABU DHABI, UAE, /PRNewswire/ -- With rising global demand for more personalised and effective ...

Scotiabank analyst George Farmer downgraded Tempest Therapeutics (TPST) to Sector Perform from Outperform with a reverse stock-split adjusted ...

The global organ on a chip market was valued at US$ 157.06 million in 2024 and is expected to reach US$ 2,238.28 million by ...

Townsville’s Perc Tucker Regional Art Gallery has a long history with ceramics, most significantly the North Queensland ...

SHEIN, the global online retailer, is returning as headline partner for the 2025 Women’s Football Awards, marking the third ...

Amezalpat (TPST-1120) is Phase 3-ready: completed FDA and EMA interactions for first-line pivotal study in hepatocellular carcinoma (HCC); global ...

Global drugmakers' stocks dropped across the board after U.S. President Donald Trump reiterated plans for a "major" tariff on ...

The Merkel cell carcinoma market is poised for steady growth, with a strong CAGR projected from 2024 to 2034. This expansion across the 7MM will be driven by the launch of innovative therapies ...

DelveInsight's Merkel Cell Carcinoma Market Insights report includes a comprehensive understanding of current treatment ...